Abstract Molecular genetic analyses in Schizosaccharomyces pombe rely on selectable markers that are used in cloning vectors or to mark targeted gene deletions and other integrated constructs. In this study, we used genetic mapping data and genomic sequence information to predict the identity of the S. pombe lys2 + gene, which is homologous to Saccharomyces cerevisiae LYS4 + . We confirmed this prediction, showing that the cloned SPAC343.16 gene can complement a lys2-97 mutant allele, and constructed the lys2 + -based cloning vector pRH3. In addition, we deleted the S. pombe his7 + gene with a lys2 + -marked polymerase chain reaction (PCR) product and the S. pombe lys2 + gene with a his7 + -marked PCR product. Strains carrying these deletions of lys2 + or his7 + serve as relatively efficient hosts for the deletion of the ade6 + gene by lys2 + -or his7 + -marked PCR products when compared with hosts carrying lys2 or his7 point mutations. Therefore, these studies provide plasmids and strains allowing the use of lys2 + as a selectable marker, along with improved strains for the use of his7 + to mark gene deletions.
Introduction
Selectable markers are essential to molecular genetic studies in the fission yeast Schizosaccharomyces pombe. They are incorporated into autonomously replicating plasmids and used to mark DNA fragments inserted into chromosomes by homologous recombination in order to delete or alter the sequence of a gene at its endogenous locus. As more molecular genetic tools are developed and strains carrying gene deletions or epitope tags at multiple loci are constructed, the number of usable selectable markers can become limiting.
The first plasmid markers used in S. pombe were Saccharomyces cerevisiae URA3 + , which complements an S. pombe ura4 -mutation, and Saccharomyces cerevisiae LEU2 + , which complements an S. pombe leu1 -mutation (Beach and Nurse 1981; Losson and Lacroute 1983) . These markers function well on multicopy plasmids; however, single copy URA3 + fails to complement a ura4 -mutant allele, while single copy LEU2 + (expressed from its own promoter) only weakly complements a leu1 -mutant allele. Therefore, these markers are generally insufficient for marking a gene deletion. Subsequently, the S. pombe ura4 + (Bach 1987; Grimm et al. 1988 ) and leu1 + (Kikuchi et al. 1988 ) genes were cloned, although while ura4 + is commonly used, the Saccharomyces cerevisiae LEU2 + gene remains the preferred marker to S. pombe leu1 + . In addition, the S. pombe his7 + (Apolinario et al. 1993) , his3 + (Burke and Gould 1994) and arg3 + (Waddell and Jenkins 1995) genes have been cloned and shown to fully restore His + and Arg + growth in single copy. Very recently, a series of cloning vectors has been constructed carrying the arg12 + , tyr1 + , ade7 + , and his2 + genes, and a vps34 + gene disruption was constructed using each marker (Fujita et al. 2005) .
In addition to biosynthetic pathway genes, drugresistance markers are used in S. pombe. The kanMX6 marker, which confers G418 R growth, is extensively used in gene deletions and epitope-tagging of chromosomal genes (Ba¨hler et al. 1998) , while the bacterial hph and nat genes confer resistance to hygromycin B and nourseothricin, respectively (Burland et al. 1991; Sato et al. 2005) . The advantage of drug resistance markers is that, except for strains already carrying these markers, all S. pombe strains are suitable hosts for transformation with Communicated by P. Sunnerhagen these markers due to their natural sensitivity to the drugs to which these markers confer resistance. In contrast, biosynthetic pathway genes can only be introduced into a host strain that is defective in that step of the pathway.
To facilitate their use in targeted gene deletions, unmarked chromosomal deletions of ura4 + (Grimm et al. 1988) , his3 + (Burke and Gould 1994) and arg3 + (Waddell and Jenkins 1995) were constructed. In addition, using a Cre-loxP system, arg12::loxP, tyr1::loxP, ade7::loxP and his2::loxP deletion alleles have also been constructed (Fujita et al. 2005) . These deletion alleles do not possess any sequences homologous to the selectable marker, thus increasing the frequency with which transformants that regain the relevant prototrophy carry the gene deletion. We have also used the SV40 promoterdriven LEU2 + selectable marker present in the pNMT-TOPO vectors (Invitrogen) for gene deletions, as there is insufficient homology between S. pombe leu1 + and Saccharomyces cerevisiae LEU2
+ to promote targeting of LEU2 + to the leu1 + locus, while the SV40 promoter allows sufficient expression of Leu2 to confer Leu + growth in single copy (Wang et al. 2004) .
In this study, we cloned the S. pombe lys2 + gene and incorporated it into a versatile cloning vector to create plasmid pRH3. In addition, we carried out polymerase chain reaction (PCR) based gene deletions of lys2 + and his7 + , marking each deletion with the other selectable marker. This work allowed us to identify PCR primers capable of amplifying each marker to produce a product that functions well in single copy. In addition, the resulting lys2D::his7 + deletion allele lacks the entire lys2 + sequence that is amplified to mark the his7D::-lys2 + deletion, while the his7D::lys2 + deletion allele lacks the entire his7 + sequence that is amplified to mark the lys2D::his7 + deletion. As expected, these strains are superior to lys2-97 and his7-366 strains for the construction of lys2 + -or his7 + -marked gene deletions when using PCR products, as demonstrated by comparing the efficiency of deleting the ade6 + gene. Thus, these studies make the his7 + marker easier to use in future gene disruptions, and provide new reagents for the use of lys2 + as a selectable marker in S. pombe.
Materials and methods

Yeast strains and growth media
Yeast strains used in this study are listed in Table 1 . Only relevant genotypes are given in the text and figures. Standard S. pombe media YEA, PM and EMM (Watanabe et al. 1988; Alfa et al. 1993) were used for culturing cells. Crosses were carried out on MEA medium (Gutz et al. 1974 ) and tetrads were dissected on YEA medium.
Cloning of lys2
+ gene SPAC343.16 (lys2 + ) was PCR-amplified from strain 972 genomic DNA using oligonucleotides lys2-for (5¢-CGTAAAAAAGAAAGAGCTGAGCG-3¢) and lys2-rev (5¢-GCAGTACGCAAAGATCCTAAGCT-3¢). The PCR product was cloned into vector pNMT41 (Invitrogen) and used to transform Escherichia coli according to the manufacturer's instructions. Plasmids from E. coli transformants were purified and screened by a HindIII digest to identify pRH1 and pRH2, which carry the insert PCR product in the two orientations relative to the nmt41 promoter.
Construction of the pRH3 lys2
+ -marked cloning vector
The lys2 + gene was PCR-amplified using oligonucleotides URA3lys2-for (5¢-GATTCGGTAATCTCCGAA CAGAAGGAAGAACGAAGGAAGGAGCACAGAC TTAGTCTGAATAATCATGCTTGAAACC-3¢) and URA3lys2-rev (5¢-CCTGATGCGGTATTTTCTCCT TACGCATCTGTGCGGTATTTCACACCGCATAT TTAGCGATGTTATTCAGCTTTAC-3¢) with plasmid pRH1 as template. The 3¢ ends of the oligonucleotides (underlined) are identical to sequences flanking lys2 + , while the 5¢ ends are identical to sequences flanking the URA3 + selectable marker in plasmid pSP2 (Cottarel et al. 1993 ). This PCR product was used to replace the URA3 + marker in plasmid pSP2 by cotransformation of strain CHP871 (lys2-97) with plasmid pSP2 (digested with NsiI and StuI) and the PCR product, following the marker-swap protocol of Kelly and Hoffman (Kelly and Hoffman 2002) , to create plasmid pRH3. (Ba¨hler et al. 1998 ) and homologous recombination events were confirmed by PCR analysis using his7testfor (5¢-GACTCGC ATGATTCCATCCATC-3¢) and his7testrev (5¢-CAG AAGGTATACACAGCGACA-3¢) or lys2testfor (5¢-CG TAAAAAAGAAAGAGCTGAGCG-3¢) and lys2testrev (5¢-GCAGTACGCAAAGATCCTAAGCT-3¢).
Construction of ade6D::his7
+ and ade6D::lys2 + deletion alleles The ade6 + gene was deleted by a one-step PCR-based method. Oligonucleotides ade6-his7for (5¢-CTATGCA GAATAATTTTTCCAACCAACTTTTTCTAATTT ATCAGCCTTTTCTAAAACCAAGCAAGGATTTC GCTATGCC-3¢) and ade6-his7rev (5¢-ATGAGCGAA AAACAGGTTGTAGGGATCCTTGGAGGTGGTCA ATTGGGCCGAATGATGGACCGACTGCTATCAT CTGCG-3¢) were used to PCR-amplify his7 + from plasmid pMN1, while oligonucleotides ade6-lys2for (5¢-CTATGCAGAATAATTTTTCCAACCAACTTTTT CTAATTTATCAGCCTTTTCTAAAAACGCATGC TACGAACTAGTCTG-3¢) and ade6-lys2rev (5¢-ATGA GCGAAAAACAGGTTGTAGGGATCCTTGGAGGT GGTCAATTGGGCCGAATGATGGTGGGAAGATA GATTGATGGAC-3¢) were used to PCR-amplify lys2 + from plasmid pRH1. Strains CHP1029 (lys2D::his7 + ), CHP1030 (his7D::lys2 + ), and CHP1031 (lys2-97 his7-366) were transformed to Lys + and His + , as appropriate (Ba¨hler et al. 1998) . The percent of Ade À transformants was scored by replica plating to EMM-ade and to YEA-ade.
Results and discussion
lys2
+ Gene prediction and cloning
The initial goal of this study was to clone and develop a new selectable marker for S. pombe, preferably in a biosynthetic pathway for which other markers are not available. While the S. pombe lys1 + gene had been cloned (Beach et al. 1982; Ford et al. 1993) , it is too large to be used as a selectable marker. We chose to pursue lys2 + , due to mapping data on the website http:// www.izb.unibe.ch/res/kohli/Chromo1.html placing it 4.3 cM from rad9 + (164 PD:1 NPD:9 TT). As rad9 + has been cloned (Murray et al. 1991) , its physical location on the chromosome is known. Other chromosome 1 cross data ( + , we PCRamplified this gene from strain 972 (lys2 + ) and cloned it into a vector that can transform S. pombe leu1-32 strains to Leu + . The PCR product includes the SPAC343.16 promoter, so that the orientation of insertion into this nmt-driven expression vector will not affect function. Plasmids pRH1 and pRH2, carrying the insert in either orientation, complement lys2-97 in strain CHP880, while failing to complement lys1-131 in strain FWP42 (Fig. 1) . Conversely, a clone of the lys1 + gene, plys1 + , which we previously obtained from a pWH5-based genomic library (Feilotter et al. 1991) , transforms FWP42, but not CHP880, to Lys + . Thus, SPAC343.16 is lys2 + .
Construction of a lys2 + -based cloning vector
Using a marker-swap protocol (Kelly and Hoffman 2002), we replaced Saccharomyces cerevisiae URA3 + in plasmid pSP2 (Cottarel et al. 1993 ) with lys2 + to create (Fig. 2) . This plasmid possesses the S. pombe ars1 to facilitate high-efficiency transformation, along with a polylinker with unique restriction sites for XhoI, EcoRI, SmaI, XmaI, BamHI, SpeI, NotI, EagI, SacII, and BxtXI. In addition, pRH3 can be used in a blue/white screen in E. coli to identify plasmids containing insert DNA. Plasmid pRH3 can transform CHP871 (lys2-97) cells to Lys + and produces blue colonies when introduced into E. coli strain TOP10 (data not shown). Thus, pRH3 should be a useful cloning vector for transforming S. pombe strains that carry markers in the more commonly used leucine, uracil and histidine biosynthetic pathways due to the presence of other plasmids or marked chromosomal insertions. Using the lys2 + -specific sequences employed in this construction (see Materials and methods), it would be a simple matter to replace the selectable marker in other S. pombe vectors with lys2 + .
Construction of lys2D::his7 + and his7D::lys2 + deletion alleles using PCR products Polymerase chain reaction-based gene deletions generally utilize long oligonucleotides whose 3¢ ends prime amplification of a selectable marker and whose 5¢ ends provide targeting sequences to target insertion into the genome by homologous recombination. We designed two sets of oligonucleotides; one to target his7 + to the lys2 + locus (lys2D::his7 + ) and a second to target lys2 + to the his7 + locus (his7D::lys2 + ). PCR amplification from plasmids pMN1 (his7 + , Apolinario et al. 1993 ) and pRH1 (lys2 + ) resulted in the expected 1.7 and 2.8 kb products (data not shown), which were used to transform strain FWP58 (his7-366) to His + and strain CHP871 (lys2-97) to Lys + . Less than one percent of transformants in each transformation acquired the corresponding auxotrophy due to homologous recombination. This low frequency is presumably due to the ability of the transforming DNA to repair his7-366 and lys2-97 at their respective loci. PCR analysis confirmed the homologous recombination events to create the lys2D::-his7 + and his7D::lys2 + alleles (Fig. 3a) in strains CHP1029 and CHP1030, respectively. As expected, the 3.2 kb product for the lys2 + locus is reduced to 2.1 kb due to its replacement with the smaller his7 + gene to create the lys2D::his7 + allele. Conversely, the 2.2 kb product for the his7 + locus is increased to 3.4 kb due to its replacement with the larger lys2 + to create the his7D::lys2 + allele (an additional 1.9 kb nonspecific band is also visible in the his7 diagnostic lanes).
This was our first attempt to use either lys2 + or his7 + in a PCR-based deletion protocol. We therefore needed to verify that these amplified products confer histidine and lysine prototrophy in single copy, so that future deletion protocols can use the same priming sequences. Fig. 1 Plasmid complementation of lys1-131 and lys2-97 mutant alleles. Strains FWP45 (lys1 + lys2 + ), FWP42 (lys1-131), and CHP880 (lys2-97) were transformed to Leu + with plasmids plys1 + (pWH5 vector carrying lys1 + genomic DNA), pRH1 (pNMT41 carrying lys2 + PCR product), pRH2 (pNMT41 carrying lys2 + PCR product inserted in the opposite orientation from that of pRH1), or pNMT41 (empty vector). A mock transformation (no plasmid) was carried out in the absence of plasmid DNA. Leu + transformants were replica plated to PM medium lacking leucine and lysine. Plasmid plys1 + is shown to complement the lys1-131 mutant allele, while plasmids pRH1 and pRH2 complement the lys2-97 allele The PCR analysis in Fig. 3a uses oligonucleotides that flank the targeting sites for each deletion, thus the size of the PCR product demonstrates that each deletion contains a single insertion of the selectable marker, as opposed to a tandem insertion. To determine whether the deletion strains CHP1029 (his7-366 lys2D::his7 + ) and CHP1030 (his7D::lys2 + lys2-97) carry insertions of the PCR products at additional genetic loci, we crossed each strain with CHP1031 (his7-366 lys2-97) and examined the segregation pattern for the His + and Lys + phenotypes in the progeny. A single integration should produce a 2:2 pattern, while integrations at multiple loci would result in other patterns depending on whether a single copy of the marker in question is sufficient to confer a His + or Lys + phenotype. As shown in Fig. 3b , all ten tetrads from each cross display a 2:2 pattern indicating the presence of a single copy of the respective markers. More than 30 additional tetrads from each cross also showed a 2:2 segregation pattern (data not shown). Therefore, single copy integrations of these his7 + -and lys2 + -marked PCR products confer His + and Lys + prototrophy, respectively.
Increased efficiency of homologous gene deletion in lys2D::his7 + and his7D::lys2 + strains
As mentioned above, we assumed that the low homologous recombination frequency observed while constructing the lys2D::his7 + and his7D::lys2 + strains was due to relatively high frequency repair of the his7-366 and lys2-97 alleles. -. Therefore, strains bearing these deletion alleles are significantly better for use in PCR-based gene deletion protocols. In addition, we have carried out subsequent crosses to produce sets of strains appropriate for the construction of diploid strains that are homozygous for lys2D::his7 + or his7D::lys2 + to be used in gene knockout experiments (see Table 1 , strains CHP1050-1057).
Conclusions
In this study, we used genetic and physical mapping information to identify the S. pombe lys2 + gene, demonstrating that three different plasmid constructs carrying this gene complement lys2-97, but not lys1-131 ( Fig. 1 ; data not shown). One of these plasmids, pRH3 (Fig. 2) , should be a useful cloning vector as it contains an S. pombe ars, conferring high efficiency transformation, and a large polylinker to accommodate a variety of cloning strategies. In addition, one can apply a blue/ white screen to identify pRH3 derivatives that carry insert DNA.
We have also demonstrated the ability to use both lys2 + and his7 + in PCR-based gene disruption constructs. In doing this, we have identified sequences (see Materials and methods) capable of PCR-amplifying these two markers such that they are functional in single copy. By deleting the his7 + gene with lys2 + and deleting the lys2 + gene with his7 + , we have created strains that are useful hosts for subsequent gene deletions. Previous efforts to use his7 + as a selectable marker for gene deletions were hampered by the fact that his7-366 can be directly repair by the transforming DNA (Apolinario et al. 1993; Jin et al. 1995; Landry et al. 2000) . As shown here, this problem is greatly enhanced when using a PCR-based strategy, since the deletion cassette possesses little sequence homology to the gene to be deleted relative to the homology between the selectable marker and the spontaneous mutant allele in the host. Since the PCR-amplified markers used in this study do not share homology with the deletion alleles, repair at the site of the deletion allele is not possible. As expected, the PCR products used to delete ade6 + produced more than tenfold fewer total transformants in strains CHP1029 (his7-366 lys2D::his7 + ) and CHP1030 (his7D::lys2 + lys2-97), than in strain CHP1031 (his7-366 lys2-97) using com- (Cottarel et al. 1993 ) with the lys2 + gene. Unique restriction sites in the polylinker are shown in bold. The relative locations of polylinker sites that are present elsewhere is the plasmid are also shown parable amounts of transforming DNA. The total number of Lys + CHP1029 transformants was especially low, possibly indicating suboptimal expression of Lys2 in this particular context, however we were readily able to identify an Ade À transformant among the seven Lys + colonies. lys2 + is one of many genes whose identities could be predicted using genetic mapping data and genomic sequence information. In fact, a list of gene predictions can be found at http://www.sanger.ac.uk/Projects/ S_pombe/genetic_map.shtml. While most genes of the methionine biosynthetic pathway have not been cloned, the fact that methionine added to the growth medium derepresses conjugation and other glucose-regulated behaviors suggests that the use of a marker in this pathway could be problematic (Schweingruber et al. 1998) . The list of predicted, but not cloned, genes includes all four tryptophan biosynthesis genes. Thus, while many biosynthetic pathway genes remain to be cloned, either trp3 + or trp4 + may be particularly useful due to their small size and the fact that no other marker from this pathway is currently in use. Fig. 3 PCR-based 
